Project Description
Cefotaxim + solvent lidocaine hydrochloride
powder + solution 5 ml
international nonproprietary name
Cefotaxime
Ref
BM-0215
Pharmacotherapeutic group
Not established
Composition of the preparation
Not established
Pharmacological action
Not established
Indications
Not established
special indication
Not established
special warning
Not established
Dosage and method of administration
1g + 10 mg/ml
overdosage
Not established
safety measures
Not established
Side effects
Not established
Contraindications
Not established
Interactions with other medicinal preparations
Not established
The form of release
powder + solution 5 ml – amount in packaging : 1+1